Transactions

Peterson Law acts for Envoy Capital Group Inc. as it completes amalgamation with Merus Labs International Inc. and lists on the Toronto Stock Exchange

On December 19, 2011, Merus Labs International Inc. (“Merus”) and Envoy Capital Group Inc. (“Envoy”) completed their amalgamation, which formed “Merus Labs International Inc.” trading on the Toronto Stock Exchange under symbol, “MLS”. In connection with the amalgamation, Envoy closed a private placement of 4,196,500 units of Envoy at a price per Envoy unit of CDN $2.00 for total gross proceeds of $8,393,000.

Merus is a specialty pharmaceutical company engaged in the acquisition and licensing of pharmaceutical products. Merus Labs utilizes its expertise in the North American pharmaceutical markets and its access to capital to acquire and license niche branded products in Canada and United States. Merus Labs further enhances the sale and distribution of these products by introduction of a focused marketing and promotion plan.

Back

Recent Transactions

31 December 2021

Peterson McVicar Acts for Bitfarms in $100 Million Credit Facility

Learn More

08 December 2021

Peterson McVicar Acts for Red Cloud in Upsize of Fission 3.0 Brokered Private Placement to up to C$7.5 Million

Learn More

11 November 2021

Peterson McVicar acts for Bitfarms as it Acquires 24 Megawatts of Hydro Power in the U.S. and Enters into Memorandum of Understanding to Expand Up to 99 MW

Learn More

09 November 2021

Peterson McVicar Acts for HIVE Blockchain in $110,020,000 Bought Deal Private Placement Financing

Learn More